PERIOGARD MOUTHWASH
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
03-12-2019
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
CHLORHEXIDINE GLUCONATE
Inapatikana kutoka:
COLGATE-PALMOLIVE CANADA INC
ATC kanuni:
A01AB03
INN (Jina la Kimataifa):
CHLORHEXIDINE
Kipimo:
0.12%
Dawa fomu:
MOUTHWASH
Tungo:
CHLORHEXIDINE GLUCONATE 0.12%
Njia ya uendeshaji:
BUCCAL
Vitengo katika mfuko:
470ML
Dawa ya aina:
Prescription
Eneo la matibabu:
MISCELLANEOUS ANTI-INFECTIVES
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0107629007; AHFS:
Idhini hali ya:
CANCELLED POST MARKET
Idhini ya tarehe:
2018-10-10
Tabia za bidhaa
Page 1 of 19
PRODUCT MONOGRAPH
PERIOGARD
Chlorhexidine Gluconate 0.12% Oral Rinse, USP
Liquid, 0.12% Chlorhexidine Gluconate
Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc. Date of Revision:
Two Morneau Shepell Centre
December 3, 2019
5
th
Floor, 895 Don Mills Road
Toronto, Ontario M3C 1W3
Submission Control No: 232067
Page 2 of 19
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................................
3
SUMMARY PRODUCT INFORMATION
.............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
.......................................................................................................................
4
WARNINGS AND PRECAUTIONS
.....................................................................................................
4
ADVERSE REACTIONS
.......................................................................................................................
5
DOSAGE AND ADMINISTRATION
.....................................................................................................
6
OVERDOSAGE
.....................................................................................................................................
7
ACTION AND CLINICAL PHARMACOLOGY
.....................................................................................
8
STORAGE AND STABILITY
................................................................................................................
9
SPECIAL HANDLING INSTRUCTIONS
............................................................................................
10
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................................. 10
PART II: SCIENTIFIC INFORMATION
..................................................................................................
11
P
Soma hati kamili
